Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression.
about
Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer.YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer.Small cell lung carcinoma cell line screen of etoposide/carboplatin plus a third agent.MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis.CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib.TGF-β1-induced epithelial-mesenchymal transition in lung cancer cells involves upregulation of miR-9 and downregulation of its target, E-cadherin.Venetoclax is effective in small cell lung cancers with high BCL-2 expression.Transcription factor E2F1 promotes EMT by regulating ZEB2 in small cell lung cancer.Protein expression of TTF1 and cMYC define distinct molecular subgroups of small cell lung cancer with unique vulnerabilities to aurora kinase inhibition, DLL3 targeting, and other targeted therapies.Small-cell lung cancer: what we know, what we need to know and the path forward.Candidate diagnostic miRNAs that can detect cancer in prostate biopsy.Overcoming resistance to DNA targeted agents by epigenetic activation of Schlafen 11 (SLFN11) expression with class I histone deacetylase inhibitors.Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification.Update on Immunohistochemistry for the Diagnosis of Lung Cancer.Targeting DNA damage repair in small cell lung cancer and the biomarker landscape.Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer
P2860
Q33709790-422238CB-1F7F-4F79-A633-AA926622AE7FQ37544346-0148A509-DAA5-474D-A145-CB226E17ABC3Q38695896-B9AFD711-FEFF-4FD2-934C-BBE033471334Q39019412-9C363126-8A6E-44F1-958B-B8EA05E5E727Q40336402-A03ED103-163C-4ABE-80F8-8735AF39CC42Q41466400-28002BA1-862B-42A7-8875-D4EB0CA1CA27Q43256240-DDF43D90-68C9-4E03-9BA4-9593B3071E09Q45072361-65C9514E-E19B-4742-8FE2-6410A32E8B2BQ47131652-0A965FF3-B8ED-470B-9E20-BF3544A19A4DQ47161308-625D1291-3077-4D34-ADA2-557E9FBE6D01Q47595394-3BD7783B-C95C-4689-A392-C872B13DDB91Q48145024-3E87B106-0DFE-4E71-A012-F8A62704C546Q49390599-34C60EB5-3BC9-42BF-A20F-E4BD10CFE887Q50143858-1388CAB2-2D22-423B-9F2D-CC211B38D2A5Q51733982-1E5014AA-480A-46DF-8238-8CE91131660BQ52657032-11D37BFD-D10C-406C-8A4E-C941CDB17C7DQ58734416-FBB24131-079D-433B-A3AE-A59CC722449B
P2860
Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Small Cell Lung Cancer Screen ...... Gene and microRNA Expression.
@ast
Small Cell Lung Cancer Screen ...... Gene and microRNA Expression.
@en
type
label
Small Cell Lung Cancer Screen ...... Gene and microRNA Expression.
@ast
Small Cell Lung Cancer Screen ...... Gene and microRNA Expression.
@en
prefLabel
Small Cell Lung Cancer Screen ...... Gene and microRNA Expression.
@ast
Small Cell Lung Cancer Screen ...... Gene and microRNA Expression.
@en
P2093
P2860
P356
P1476
Small Cell Lung Cancer Screen ...... d Gene and microRNA Expression
@en
P2093
Anne Monks
Beverly A Teicher
David Evans
Eric Polley
Erik Harris
Gurmeet Kaur
Joel Morris
John Connelly
Julie Laudeman
P2860
P356
10.1093/JNCI/DJW122
P407
P577
2016-05-31T00:00:00Z